Jennifer Levin Carter, M.D., MPH, MBA

Venture Partner

Jennifer is a Managing Director of the Blue Venture Fund.

She currently serves on the Board and/or as a strategic advisor to multiple public and private precision medicine, healthcare services, digital health and life science companies. Prior to Sandbox Industries, Jennifer served as a Managing Director of JLC Precision Health Strategies, LLC and in 2018, she founded TrialzOWN, Inc., a healthcare company in stealth, and was CEO until its prelaunch acquisition by the Flagship Pioneering company, Integral Health, (now Valo Health), in 2019. Prior to TrialzOWN™, she was the Founder and President of N-of-One®, Inc, serving as acting-CEO from 2008-2012, and Chief Medical Officer from 2012 until its acquisition by Qiagen (Market Cap $8B) in 2019. 

Jennifer graduated Phi Beta Kappa, Summa Cum Laude with distinction with a BS in Molecular Biophysics and Biochemistry from Yale University, an MD from Harvard Medical School, an MPH from Harvard School of Public Health, and an MBA from the Sloan School at Massachusetts Institute of Technology.